Glaukos Corp. (GKOS) Tops Q4 EPS by 6c; FY16 Revenue Outlook Flat with Views

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. TENB
7. BIIB
8. CMG
9. KLAC
10. ETSY

Go back to Glaukos Corp. (GKOS) Tops Q4 EPS by 6c; FY16 Revenue Outlook Flat with Views

Glaukos Corporation Announces Fourth Quarter & Full Year 2015 Financial Results

March 1, 2016 4:15 PM EST

LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced financial results for the fourth quarter and full year ended December 31, 2015. Key highlights include:

Achieved 44% growth in net sales to $20.3 million in the fourth quarter of 2015, compared to $14.1 million in the fourth quarter of 2014. Reported 57% growth in net sales to $71.7 million for 2015, compared to $45.6 million in 2014.... More